ImageneBio

IMANasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$54.601 M

$4.81 -1.64%

Close of 21 Sept 2026

Revenue

$800.0K

#3499 by revenue

Earnings

-$45.3M

Loss-making

Shares outstanding

11,351,456

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 160 →

#125ExozymesEXOZ$57.0M
#126Greenland MinesGRML$55.1M
#127ImageneBioIMA$54.6M
#128Black Hawk AcquisitionBKHA$49.8M
#129TevogenTVGN$48.4M

What if ImageneBio were worth as much as…

Open the what-if tool →

Gold $30.3T

$2,666,975

Per share 554,465× higher

Bitcoin $1.72T

$151,505.12

Per share 31,498× higher

Nvidia $5.48T

$482,744.95

Per share 100,363× higher

Or at a round number

$100.0M $200.0M $500.0M $1.00B

Where these numbers come from

Share counts and financials for ImageneBio are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.